Structure Therapeutics Share Price Today
(NASDAQ: GPCR)

Name: Structure Therapeutics Share Price Today (NASDAQ: GPCR) - Structure Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Structure Therapeutics share price is $29.97 & ₹2,596.60 as on 1 Feb 2025, 2.30 'hrs' IST

$29.97

▲

-0.35

(-1.15%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Structure Therapeutics share price in Dollar and Rupees. Guide to invest in Structure Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Structure Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Structure Therapeutics share price movements

Today's Low: $29.78
Today's High: $31.72
$29.97
0.63%
Downside
Day's Volatility :6.12%
Upside
5.52%
52 Weeks Low: $23.50
52 Weeks High: $62.74
$29.97
21.59%
Downside
52 Weeks Volatility :62.54%
Upside
52.23%

Structure Therapeutics (GPCR) Returns

Period	Structure Therapeutics, Inc.	Index (Russel 2000)
3 Months	-24.58%	0.0%
6 Months	-16.82%	0.0%
1 Year	-32.92%	0.0%
3 Years	15.27%	-13.7%

Structure Therapeutics (GPCR) Key Statistics

in dollars & INR

Previous Close	$30.32
Open	$30.62
Today's High	$31.72
Today's Low	$29.78
Market Capitalization	$1.7B
Today's Volume	$392.5K
52 Week High	$62.74
52 Week Low	$23.5
Revenue TTM	$0.0
EBITDA	$-121.8M
Earnings Per Share (EPS)	$-2.16
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.69%

How to invest in Structure Therapeutics Stock (GPCR) from India?

It is very easy for Indian residents to invest directly in Structure Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Structure Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Structure Therapeutics or GPCR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Structure Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Structure Therapeutics shares which would translate to 0.029 fractional shares of Structure Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Structure Therapeutics, in just a few clicks!

Returns in Structure Therapeutics (GPCR) for Indian investors in Rupees

The Structure Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Structure Therapeutics investment value today

Current value as on today

₹71,636

Returns

₹28,364

(-28.36%)

Returns from Structure Therapeutics Stock

₹32,923 (-32.92%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Structure Therapeutics (GPCR)

-80%

Period: Jan 2, 2025 to Feb 1, 2025. Change in 30 Days versus previous period

Search interest for Structure Therapeutics Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Structure Therapeutics

Buy

92%Buy

7%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Structure Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Structure Therapeutics Stock (GPCR)

What analysts predicted

Upside of 176.94%

Target:

$83.00

Current:

$29.97

Insights on Structure Therapeutics Stock (Ticker Symbol: GPCR)

Price Movement
In the last 7 days, GPCR stock has moved up by 6.2%
GPCR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 55.1% return, outperforming this stock by 88.6%

Structure Therapeutics Technicals Summary

Sell

Neutral

Buy

Structure Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Structure Therapeutics (GPCR) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Structure Therapeutics, Inc.	6.31%	-16.82%	-32.92%	15.27%	15.27%
Biontech Se	7.35%	57.95%	32.59%	-29.28%	275.97%
Regeneron Pharmaceuticals, Inc.	-5.9%	-37.18%	-28.13%	8.42%	89.04%
Vertex Pharmaceuticals Incorporated	13.78%	-3.19%	7.65%	89.41%	92.64%
Alnylam Pharmaceuticals, Inc.	16.13%	2.38%	58.94%	90.38%	126.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Structure Therapeutics, Inc.	NA	NA	NA	-0.76	-0.18	-0.13	NA	9.76
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.89	16.89	1.06	44.96	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.15	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Structure Therapeutics, Inc.	Buy	$1.7B	15.27%	NA	0.0%
Biontech Se	Buy	$29.0B	275.97%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.1B	89.04%	16.89	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$112.9B	92.64%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.7B	126.17%	NA	-15.86%

Structure Therapeutics Dividend announcements

Structure Therapeutics Earnings
Structure Therapeutics’s price-to-earnings ratio stands at None
Read More

About Structure Therapeutics

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company's lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. It is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist for apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF); and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF and PPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Organization	Structure Therapeutics
Employees	136
CEO	Dr. Raymond C. Stevens Ph.D.
Industry	Healthcare

Management People of Structure Therapeutics

Name	Title
Dr. Raymond C. Stevens Ph.D.	CEO & Director
Mr. Jun S. Yoon	Co- Founder, CFO & Secretary
Dr. Yingli Ma Ph.D.	Chief Technology Officer
Dr. Xichen Lin Ph.D.	Chief Scientific Officer
Mr. Tony Peng	Senior Vice President of Legal
Mr. Bob Gatmaitan	Senior Vice President of People
Dr. Hui Lei Ph.D.	Senior Vice President of Chemistry
Dr. Fang Zhang Ph.D.	Executive VP & Head of Biology
Ms. Lani Ibarra	Senior Vice President of Clinical Development Operations
Dr. Xinglong Jiang Ph.D.	Senior Vice President of Preclinical Development

Important FAQs about investing in GPCR Stock from India :

What is Structure Therapeutics share price today?

Structure Therapeutics share price today stands at $29.97, Open: $30.62 ; Previous Close: $30.32 ; High: $31.72 ; Low: $29.78 ; 52 Week High: $62.74 ; 52 Week Low: $23.50.

The stock opens at $30.62, after a previous close of $30.32. The stock reached a daily high of $31.72 and a low of $29.78, with a 52-week high of $62.74 and a 52-week low of $23.50.

Can Indians buy Structure Therapeutics shares?

Yes, Indians can invest in the Structure Therapeutics (GPCR) from India.

With INDmoney, you can buy Structure Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Structure Therapeutics at zero transaction cost.

How can I buy Structure Therapeutics shares from India?

It is very easy to buy Structure Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Structure Therapeutics (GPCR) be purchased?

Yes, you can buy fractional shares of Structure Therapeutics with INDmoney app.

What are the documents required to start investing in Structure Therapeutics stocks?

To start investing in Structure Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.